Vaximm starts trial of oral pancreatic cancer vaccine; Hospital fined for improper vaccine storage;

> Merck KGaA spin-off VAXIMM has kicked off its first clinical trial of oral pancreatic cancer vaccine VXM01. Release

> Soligenix has started development of a next generation anthrax vaccine as part of an agreement with Harvard University. Release

> The Daily Beast explores in a lengthy article asking whether cancer vaccines could be the key to defeating the disease. Article

> GeoVax Labs' gas inoculated the first patient in a Phase I/II trial of the company's therapeutic HIV/AIDS vaccine. GeoVax release

And Finally... South San Francisco's Kaiser Foundation Hospital was fined $50,000 for storing vaccines with a "do not freeze" warning in sub-freezing temperatures for up to 32 months. Report

Suggested Articles

Daiichi Sankyo says it still unable to fulfill a government mandate to be able to produce enough H5N1 flu vaccine to fight an epidemic in Japan.

GSK’s Shingrix has continuously impressed industry watchers with its growth, and the company just added another large market to its list: China.

WuXi Biologics says it will build a dedicated facility to manufacture a commercial vaccine product for a client in a $3 billion contract.